Intellia Therapeutics (NTLA) Return on Sales (2015 - 2026)
Intellia Therapeutics (NTLA) reported Return on Sales of 0.06% for Q1 2026, little changed year-over-year from 0.06% in Q1 2025, and down 58.09% on a QoQ basis from 0.04% in Q4 2025.
Intellia Therapeutics (NTLA) has 12 years of Return on Sales data on file, last reported at 0.06% in Q1 2026.
- Quarterly Return on Sales changed 0.0% year-over-year to 0.06% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.06% (up 5.0% YoY) and the FY2025 annual result came in at 0.06%, up 2.0% from the prior year.
- Return on Sales declined to 0.06% in Q1 2026 per NTLA's latest filing, from 0.04% in the prior quarter.
- Across five years, Return on Sales topped out at 0.66% in Q4 2023 and bottomed at 0.18% in Q2 2024.
- The 5-year median for Return on Sales is 0.08% (2022), against an average of 0.04%.
- The widest annual swing landed in 2022, when Return on Sales surged 231 bps; it then sank 76 bps in 2024.
- Tracing NTLA's Return on Sales over 5 years: stood at 0.08% in 2022, then soared by 961 bps to 0.66% in 2023, then slumped by 115 bps to 0.1% in 2024, then soared by 59 bps to 0.04% in 2025, then tumbled by 58 bps to 0.06% in 2026.
- Per Business Quant, the three latest NTLA Return on Sales figures stand at 0.06% (Q1 2026), 0.04% (Q4 2025), and 0.08% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.00% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.00% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.00% |
| 10 | Intellia Therapeutics | 1.63 Bn | 1.63 Bn | - | -0.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.06% |
| Dec 31, 2025 | -0.04% |
| Sep 30, 2025 | -0.08% |
| Jun 30, 2025 | -0.07% |
| Mar 31, 2025 | -0.07% |
| Dec 31, 2024 | -0.10% |
| Sep 30, 2024 | -0.15% |
| Jun 30, 2024 | -0.18% |
| Mar 31, 2024 | -0.04% |
| Dec 31, 2023 | 0.66% |
| Sep 30, 2023 | -0.10% |
| Jun 30, 2023 | -0.09% |
| Mar 31, 2023 | -0.08% |
| Dec 31, 2022 | -0.08% |
| Sep 30, 2022 | -0.08% |
| Jun 30, 2022 | -0.07% |
| Mar 31, 2022 | -0.13% |
| Dec 31, 2021 | -0.06% |
| Sep 30, 2021 | -2.39% |
| Jun 30, 2021 | -0.11% |
| Mar 31, 2021 | -0.07% |
| Dec 31, 2020 | -0.06% |
| Sep 30, 2020 | -0.01% |
| Jun 30, 2020 | -0.02% |
| Mar 31, 2020 | -0.06% |
| Dec 31, 2019 | -0.03% |
| Sep 30, 2019 | -0.02% |
| Jun 30, 2019 | -0.02% |
| Mar 31, 2019 | -0.02% |
| Dec 31, 2018 | -0.02% |
| Sep 30, 2018 | -0.03% |
| Jun 30, 2018 | -0.03% |
| Mar 31, 2018 | -0.03% |
| Dec 31, 2017 | -0.04% |
| Sep 30, 2017 | -0.02% |
| Jun 30, 2017 | -0.03% |
| Mar 31, 2017 | -0.02% |
| Dec 31, 2016 | -0.02% |
| Sep 30, 2016 | -0.02% |
| Jun 30, 2016 | -0.02% |
| Mar 31, 2016 | -0.04% |
| Dec 31, 2015 | -0.03% |
| Sep 30, 2015 | -0.02% |
| Jun 30, 2015 | -0.02% |
| Mar 31, 2015 | -0.01% |